Page 11 - Cachexia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cachexia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cachexia Today - Breaking & Trending Today

Study gives new clues to how muscle wasting occurs on a cellular level

Muscle wasting, or the loss of muscle tissue, is a common problem for people with cancer, but the precise mechanisms have long eluded doctors and scientists. Now, a new study led by Penn State researchers gives new clues to how muscle wasting happens on a cellular level. ....

United States , Gustavo Nader , Emily Henderson , Penn State , Associate Professor , American Societies , Experimental Biology , Muscle Wasting , Mouse Model , Ovarian Cancer , Protein Synthesis , ஒன்றுபட்டது மாநிலங்களில் , குஸ்டாவோ நாடர் , எமிலி ஹென்டர்சன் , பென் நிலை , இணை ப்ரொஃபெஸர் , அமெரிக்கன் சமூகங்கள் , சோதனை உயிரியல் , சுட்டி மாதிரி , ஓவாயரியந் புற்றுநோய் , ப்ரோடீந் தொகுப்பு ,

Helsinn Healthcare S.A.: ONO Receives a Manufacturing and Marketing Approval of Adlumiz (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan

Helsinn Healthcare S.A.: ONO Receives a Manufacturing and Marketing Approval of Adlumiz (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan
Not intended for US media
Lugano, Switzerland, and Osaka, Japan, January 22, 2021 - Helsinn Group (Lugano, Switzerland; CEO: Riccardo Braglia, Helsinn ) and Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and Representative Director: Gyo Sagara; ONO ) announced today that ONO received the manufacturing and marketing approval of Adlumiz (generic name: anamorelin hydrochloride) Tablet 50mg ( Adlumiz ), a ghrelin receptor agonist, for the treatment of cancer cachexia in malignant tumors of non-small cell lung cancer, gastric cancer, pancreatic cancer or colorectal cancer in Japan. ....

South Korea , Kiyoaki Idemitsu , Paola Bonvicini , Adlumiz Anamorelin , Riccardo Braglia , Gyo Sagara , Helsinn Group Vice , Swiss Pharma Company , Group Head Of Communication , Helsinn Group Media Contact , Corporate Communications , Ono Pharmaceutical Co Ltd , Helsinn Group , Helsinn Group Lugano , Clinical Development , Marketing Approval , Ghrelin Receptor Agonist , Cancer Cachexia , Representative Director , Helsinn Group Vice Chairman , Corporate Executive Officer , Executive Director , Adlumiz Tablet , Management Plan , Helsinn Healthcare , Health Care ,